FAS2 2023 still lists Theophylline but says (rarely used due to narrow therapeutic window). Amboss states Theophylline should be avoided as risks outweigh benefits. Fine with removing Theophylline personally (and should add note in extra section), but not sure adding “High dose” for SABA and SAMA treatment is necessary. Card is also tagged as delete. @Ahmed7 @shmuelsash @Sameem @herstein.jacob @Cameron
Support moving theophylline to extra / or remove it, we already cover theophylline a lot for step 1. Don’t know if High SABA/SAMA makes any sense, we just give three puffs of normal dose SABA, and if it doesn’t work, we just move to nebulization of SABA.
I believe this is the nid we replaced nid:1474580971787
if everyone agrees with nid:1474580971787 then we can just reject this suggestion since its a delete card (or accept so this duplicate note appears in extra)
Agree, should add note to extra section that card is a duplicate of nid:1474580971787
Prefer to reject + manually add the duplicate warning in red
Agree with @herstein.jacob